Methods and systems of using exosomes for determining phenotypes
AssigneeCaris Life Sciences Luxembourg Holdings, S.A.R.L.
InventorsMichael Klass, Christine Kuslich, George Poste
Life of this patent
Estimating the term…
Loading patent…
AssigneeCaris Life Sciences Luxembourg Holdings, S.A.R.L.
InventorsMichael Klass, Christine Kuslich, George Poste
Estimating the term…
Exosomes can be used for detecting biomarkers for diagnostic, therapy-related or prognostic methods to identify phenotypes, such as a condition or disease, for example, the stage or progression of a disease. Cell-of-origin exosomes can be used in profiling of physiological states or determining phenotypes. Biomarkers or markers from cell-of-origin specific exosomes can be used to determine treatment regimens for diseases, conditions, disease stages, and stages of a condition, and can also be used to determine treatment efficacy. Markers from cell-of-origin specific exosomes can also be used to identify conditions of diseases of unknown origin.
A method of detecting an exosome population in a biological sample, comprising determining the presence or levels of a combination of different biomarkers of said exosome population, wherein said combination of different biomarkers comprises:
A method of detecting prostate cancer in a patient comprising:
Dependencies are inferred from the claim text.